• Explore /
  • Videos & Slides
  • / Prospective randomized multicenter phase III trial comparing perioperative chemotherapy (FLOT protocol) to neoadjuvant chemoradiation (CROSS protocol) in patients with adenocarcinoma of the esophagus (ESOPEC trial).

Prospective randomized multicenter phase III trial comparing perioperative chemotherapy (FLOT protocol) to neoadjuvant chemoradiation (CROSS protocol) in patients with adenocarcinoma of the esophagus (ESOPEC trial).

Abstract Video & Slides

Presenter

Jens Hoeppner

Jens Hoeppner, MD, FAChirg

University of Bielefeld

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Videos & Slides Details

Meeting

2024 ASCO Annual Meeting

Session Type

Plenary Session

Session Title

Plenary Session

Track

Special Sessions

Sub Track

Esophageal or Gastric Cancer - Local-Regional Disease

Clinical Trial Registration Number

NCT02509286

Citation

J Clin Oncol 42, 2024 (suppl 17; abstr LBA1)

DOI

10.1200/JCO.2024.42.17_suppl.LBA1

Abstract #

LBA1

Abstract Disclosures

Similar Videos & Slides

Speaker: Deborah Schrag

Speaker: Deborah Schrag, MD, FASCO, MPH

Speaker: John V. Reynolds, BCh, FRCS, MA, MB, MCh

Speaker: Manish A. Shah, MD, FASCO